E URO pean network of transnational collaborative RTD projects in the field of NANOMED icine

1 www.euronanomed.net

EUROpean network of transnational collaborative RTD projects

in the field of NANOMEDicine

www.euronanomed.net2

What are the societal needs? - the challenge for Europe

Improve public health and welfare– Ageing population– Efficiency of current medical

solutions– Emergence of new disease and old

diseases are back– Personalized medicine future

directions


The global challenge

• Therapeutic solutions for only 1/3 known diseases (WHO)

• Infections: HIV, TB, malaria, risk of pandemia

• Need to increase capability and innovation of medical industry– Rapid and accurate diagnosis for

early detection, even prevention– Novel, more efficient therapies with

less side effects


Nano from research to patient and industry

Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare

Foto: kaibara87/www.flickr.com


Emerging nanomedicine

Lancet Infectious Diseases

April issue, vol 9, 2009


Principle of theERA-net scheme

F

GUK

ES

DE

CP

CPCP

CP

CPWithout ERA-Net

Prog F

Prog G

Prog UK

ProgES

ProgDE

Common transnational dedicated CP

With ERA-Net

…

(CP: Call for projects)

€ : EC supports the coordination costs. Each national programme supports their national partners within the selected projects


EuroNanoMed covers 3/4 of European

nanomedicine actors• 24 partners from 18

countries/regions• Coordination of funding

programmes in nanomedicine

• Started January 2009

• EU funding for coordination for coordination ((ERA-net in FP7)

2 common joint calls for proposals 2009, 2010


EuroNanoMed: an asset to bridge the gap

2 calls to support RTD projects aiming at– solving an unmet medical need using

nanomedicine– promoting a multidisciplinary translational

approach with an international focus

EuroNanoMed will achieve a critical mass of actors !!!


EuroNanoMed outputs

• Develop innovative diagnostic and therapeutic solutions for the patient, enhancing the competitiveness of the European health industry

• Maturation of the field To bring together

– academic teams – clinical/public health teams– industrial research teams

• Cross-border collaboration between the best researchers/teams in nanomedicine


Why now? What’s the urgency?

• Health industry: a key for future growth

• European countries invest substantially in nano industry and basic nano research

• Nano technologies: a promising

field for innovation and patient applicationDespite these efforts, Europe is lagging behind the US in an increasing competition :

Europe needs to act now!


Expected outcome

• To move innovation from knowledge to industrial technology and health care applications

• Opening the national programmes to support transnational RTD partnerships

Long term vision: formula for an European-

wide integrated programme with a coordinated funding


Contacts• Coordinator and Executive Board Chair

Dr. Pierre-Noël LIRSAC Commissariat à l’Energie Atomique (CEA)[email protected], [email protected] (+33) 1 69 08 87 99

• Network Steering Committee chair Associate Prof. Karin Forsberg-NilssonSwedish research Council (SRC)[email protected]


EuroNanoMed ERA

Networking towards ERA!


EuroNanoMed First joint transnational call

for proposals

18 partners

16 countries/regions


Funding organisations in the first call for proposals• Industry, Trade and Tourism Department, Basque Government (ITT), Basque region

(Spain)• Swiss National Science Foundation (SNSF), Switzerland• VDI Technologiezentrum GmbH, Germany• Instituto de Salud Carlos III (ISCIII), Spain • The French National Research Agency (ANR), France• The Chief Scientist Office, The Ministry of Health (CSO-MOH), Israel• The Icelandic Centre for Research (RANNIS), Iceland• The Latvian Academy of Sciences (LAS), Latvia• SenterNovem, The Netherlands• National Centre for Research and Development (NCBiR), Poland• Fundacao para a Ciencia e a Tecnologia (FCT), Portugal• National Center for Programme Management (CNMP), Romania• The Swedish Research Council (SRC)(Vetenskapsrådet), Sweden• The Swedish Governmental Agency for Innovation Systems (VINNOVA ), Sweden• The Scientific and Technological Research Council of Turkey (TUBITAK), Turkey• Science Council of Lithuania (LSC), Lithuania• Economic development, research and innovation Directorate, Veneto region (Italy)• Ministry of the Walloon Region: Operational General Directorate for Economy,

Employment, and Research (DGOEER), Walloon Region (Belgium)


Topics

• Diagnostics

• Targeted drug delivery

• Regenerative medicine


Aim of the 1st call for proposals

• To find new medical solutions

• To enable an effective multi-national collaboration on research projects– Promoting multidisciplinary efforts– Encouraging translational research proposals that

combine either basic/clinical and/or industrial approach

– Having an added value in funding the transnational collaboration over the individual projects

• To support novel, ambitious ideas and possibility of application to end users


Eligibility criteria

Consortia with room for flexibility– 3 -7 partners from at least three partnering countries

– At least one clinical/public health research team and/or one industrial research team per consortium

– At least two categories (academic/clinical/industrial teams)

– Project consortium partners´ eligibility depends upon national regulation


Funding, 1st call

• Indicative total funding 15-20 M€

• Funding for up to 3 years

• Selected projects receive funding directly from their corresponding national/regional funding bodies after meeting their national regulations


Time lines, 1st call

• Call opens: May 25th 2009

• Call closes: September 1st 2009

• Funding decision: December 2009


For more information

• EuroNanoMed Call officeVeneto Nanotech s.c.p.a.

Via San Crispino, 10635129 Padova – Italy

: +39 049 7705520

email: [email protected]: www.euronanomed.net

• National/regional contacts

mailto:[email protected]

http://www.euronanomed.net/


The EuroNanoMed Electronic Submission System

• Read carefully The Guidelines for Applicants* and contact your National / Regional Contact Point (info + national applicable rules)

• Register by clicking on the link ”to register” on the homepage http://www.euronanomed.net/*; you will receive an email confirming your registration

• Accede to the EuroNanoMed Electronic Submission System* (Use the username and password you chose for the registration) fill in all the details and upload your proposal document (pdf format only), which you have previously filled in on your computer (see The Proposal Template)*.

• Submit your proposal : Click on “submit proposal” to confirm your submission; you will receive an email confirming its receipt.

• Deadline is 01 September 2009 at 17:00:00 (Brussels local time)

Modify your data at any time until the submission deadline. It is strongly recommended to transfer the final version in proper time before this date


In case of Problem…

Please contact:

• The EuroNanoMed Call Office– Monday to Thursday 9:00-13:00 and 14:30-18:00, – Friday 9:00-13:00 and 14:30-17:00 (Brussels local

time)

: +39 049 7705520 - Fax. +39 049 770555email: [email protected]

• or your National/Regional Agency contact point.


Together we are building Nanomedicine for the future!

Documents

E URO pean network of transnational collaborative RTD projects in the field of NANOMED icine